366 related articles for article (PubMed ID: 34367840)
21. Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers?
Dreyse J; Díaz O; Repetto PB; Morales A; Saldías F; Lisboa C
Int J Chron Obstruct Pulmon Dis; 2015; 10():525-33. PubMed ID: 25792820
[TBL] [Abstract][Full Text] [Related]
22. Microalbuminuria, von Willebrand factor and fibrinogen levels as markers of the severity in COPD exacerbation.
Polatli M; Cakir A; Cildag O; Bolaman AZ; Yenisey C; Yenicerioglu Y
J Thromb Thrombolysis; 2008 Oct; 26(2):97-102. PubMed ID: 17622488
[TBL] [Abstract][Full Text] [Related]
23. Predicting severe chronic obstructive pulmonary disease exacerbations using quantitative CT: a retrospective model development and external validation study.
Chaudhary MFA; Hoffman EA; Guo J; Comellas AP; Newell JD; Nagpal P; Fortis S; Christensen GE; Gerard SE; Pan Y; Wang D; Abtin F; Barjaktarevic IZ; Barr RG; Bhatt SP; Bodduluri S; Cooper CB; Gravens-Mueller L; Han MK; Kazerooni EA; Martinez FJ; Menchaca MG; Ortega VE; Iii RP; Schroeder JD; Woodruff PG; Reinhardt JM
Lancet Digit Health; 2023 Feb; 5(2):e83-e92. PubMed ID: 36707189
[TBL] [Abstract][Full Text] [Related]
24. Multi-component assessment of chronic obstructive pulmonary disease: an evaluation of the ADO and DOSE indices and the global obstructive lung disease categories in international primary care data sets.
Jones RC; Price D; Chavannes NH; Lee AJ; Hyland ME; Ställberg B; Lisspers K; Sundh J; van der Molen T; Tsiligianni I;
NPJ Prim Care Respir Med; 2016 Apr; 26():16010. PubMed ID: 27053297
[TBL] [Abstract][Full Text] [Related]
25. Relationship between BODE index, quality of life and inflammatory cytokines in COPD patients.
Sarioglu N; Alpaydin AO; Coskun AS; Celik P; Ozyurt BC; Yorgancioglu A
Multidiscip Respir Med; 2010 Apr; 5(2):84-91. PubMed ID: 22958780
[TBL] [Abstract][Full Text] [Related]
26. Soluble urokinase-type plasminogen activator receptor as a measure of treatment response in acute exacerbation of COPD.
AboEl-Magd GH; Mabrouk MM
J Bras Pneumol; 2018; 44(1):36-41. PubMed ID: 29538541
[TBL] [Abstract][Full Text] [Related]
27. CODEXS: A New Multidimensional Index to Better Predict Frequent COPD Exacerbators with Inclusion of Depression Score.
Deng D; Zhou A; Chen P; Shuang Q
Int J Chron Obstruct Pulmon Dis; 2020; 15():249-259. PubMed ID: 32099350
[TBL] [Abstract][Full Text] [Related]
28. [Establishment and verification of risk prediction model of acute exacerbation of chronic obstructive pulmonary disease based on regression analysis].
Wang M; Cai K; Shi D; Tu X; Zhao H; Li S; Li J
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Jan; 33(1):64-68. PubMed ID: 33565403
[TBL] [Abstract][Full Text] [Related]
29. Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.
Keam SJ; Keating GM
Treat Respir Med; 2004; 3(4):247-68. PubMed ID: 15350163
[TBL] [Abstract][Full Text] [Related]
30. Relationship between the presence of bronchiectasis and acute exacerbation in Thai COPD patients.
Kawamatawong T; Onnipa J; Suwatanapongched T
Int J Chron Obstruct Pulmon Dis; 2018; 13():761-769. PubMed ID: 29535516
[TBL] [Abstract][Full Text] [Related]
31. [The role of 4-hydroxynonenal in assessment of chronic obstructive pulmonary disease severity].
Liu H; Xu JY
Zhonghua Jie He He Hu Xi Za Zhi; 2012 Oct; 35(10):758-61. PubMed ID: 23289993
[TBL] [Abstract][Full Text] [Related]
32. Association of pectoralis muscle area on computed tomography with airflow limitation severity and respiratory outcomes in COPD: A population-based prospective cohort study.
Zhou K; Wu F; Zhao N; Zheng Y; Deng Z; Yang H; Wen X; Xiao S; Yang C; Chen S; Zhou Y; Ran P;
Pulmonology; 2023 Mar; ():. PubMed ID: 36907812
[TBL] [Abstract][Full Text] [Related]
33. The cross-sectional and longitudinal association of the BODE index with quality of life in patients with chronic obstructive pulmonary disease.
Lin YX; Xu WN; Liang LR; Pang BS; Nie XH; Zhang J; Wang H; Liu YX; Wang DQ; Xu ZY; Wang HW; Zhang HS; He ZY; Yang T; Wang C
Chin Med J (Engl); 2009 Dec; 122(24):2939-44. PubMed ID: 20137478
[TBL] [Abstract][Full Text] [Related]
34. [Systemic inflammation among stable ex smokers with chronic obstructive pulmonary disease].
Morales S A; Dreyse D J; Díaz P O; Saldías P F; Carrasco M; Lisboa B C
Rev Med Chil; 2010 Aug; 138(8):957-64. PubMed ID: 21140052
[TBL] [Abstract][Full Text] [Related]
35. Detection and study of plasma D-dimer change in patients with acute exacerbation of chronic obstructive pulmonary disease.
Liu BH; Sun MX; Zhou N; Li YP; Wang MZ; Yu J; Zhou HS
J Biol Regul Homeost Agents; 2016; 30(3):839-845. PubMed ID: 27655508
[TBL] [Abstract][Full Text] [Related]
36. Small pulmonary vascular alteration and acute exacerbations of COPD: quantitative computed tomography analysis.
Wang Z; Chen X; Liu K; Xie W; Wang H; Wei Y; Tang L; Zhu Y
Int J Chron Obstruct Pulmon Dis; 2016; 11():1965-71. PubMed ID: 27578971
[TBL] [Abstract][Full Text] [Related]
37. Clinical Features according to the Frequency of Acute Exacerbation in COPD.
Lee SJ; Lee SH; Kim YE; Cho YJ; Jeong YY; Kim HC; Kim JH; You JJ; Yoon CH; Lee JD; Hwang YS
Tuberc Respir Dis (Seoul); 2012 Apr; 72(4):367-73. PubMed ID: 23227078
[TBL] [Abstract][Full Text] [Related]
38. Circulating JNK pathway-associated phosphatase: A novel biomarker correlates with Th17 cells, acute exacerbation risk, and severity in chronic obstructive pulmonary disease patients.
Gao W; Gao L; Yang F; Li Z
J Clin Lab Anal; 2022 Jan; 36(1):e24153. PubMed ID: 34918391
[TBL] [Abstract][Full Text] [Related]
39. The Significance of Serum Interleukin-8 in Acute Exacerbations of Chronic Obstructive Pulmonary Disease.
Zhang J; Bai C
Tanaffos; 2018 Jan; 17(1):13-21. PubMed ID: 30116274
[TBL] [Abstract][Full Text] [Related]
40. Impact of COPD exacerbations on patient-centered outcomes.
Cote CG; Dordelly LJ; Celli BR
Chest; 2007 Mar; 131(3):696-704. PubMed ID: 17356082
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
